[Form 4] NCS Multistage Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Form 4 disclosure for NCS Multistage Holdings, Inc. (NCSM) Director Valerie A. Mitchell reported sales on 08/04/2025 and 08/05/2025 totaling 2,517 common shares: 548 shares sold at a weighted-average price of $30.00 and 1,969 shares sold at a weighted-average price of $30.16. Beneficial ownership following the transactions is reported as 25,520 shares after the 08/04 sale and 23,551 shares after the 08/05 sale.

The filing notes inclusion of 4,339 restricted stock units (RSUs) that vest and settle on February 28, 2026 and 19,212 vested RSUs that settle within 30 days after termination or a change of control. The form is signed by attorney-in-fact Ori Lev on 08/05/2025 and the reporting person is identified as a Director. The filer discloses weighted-average price ranges and offers to provide a full breakdown of sale prices on request.

Positive

• Transparent pricing disclosure: filing reports weighted-average prices and offers to provide a full breakdown of sales by price on request.
• RSU detail provided: includes explicit counts and settlement/vesting dates for RSUs (4,339 vesting on 02/28/2026 and 19,212 vested RSUs).
• Signed and dated: form signed by attorney-in-fact Ori Lev on 08/05/2025, indicating a completed Section 16 filing.

Negative

• Insider disposals: Director Valerie A. Mitchell sold a total of 2,517 shares (548 and 1,969) on 08/04/2025 and 08/05/2025.
• Reduction in reported holdings: beneficial ownership decreases from 25,520 to 23,551 shares following the reported transactions.

Insights

Financial Analyst

TL;DR: Director sold 2,517 shares at ~ $30; holdings reported at 23,551 after trades—routine Section 16 disclosures with limited standalone valuation impact.

The Form 4 shows two disposal transactions on 08/04/2025 and 08/05/2025 totaling 2,517 shares sold at weighted-average prices of $30.00 and $30.16. Post-transaction beneficial ownership is reported as 25,520 and then 23,551 shares respectively. The filing explicitly identifies RSU components—4,339 vesting Feb 28, 2026 and 19,212 vested RSUs with defined settlement triggers—which clarifies the composition of reported holdings.

As presented, the disclosure is factual and procedural; it does not include guidance or material corporate events that would, by itself, alter revenue or earnings projections.

Corporate Governance Expert

TL;DR: Filing complies with Section 16 formatting and provides price ranges and RSU details; signed by attorney-in-fact on 08/05/2025.

The Form 4 identifies the reporting person as a Director and records two sale transactions with weighted-average prices and an offer to provide a full breakdown of prices. It discloses the nature of indirect ownership by specifying RSU vesting and settlement conditions, which improves transparency around beneficial ownership calculations.

The signature by an attorney-in-fact (Ori Lev) dated 08/05/2025 is included, indicating an executed filing. No governance violations, grants, or other material corporate actions are reported in this form.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mitchell Valerie A

(Last) (First) (Middle)

C/O NCS MULTISTAGE HOLDINGS, INC.

19350 STATE HIGHWAY 249, SUITE 600

(Street)

HOUSTON TX 77070

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NCS Multistage Holdings, Inc. [ NCSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/04/2025		S		548	D	$30(1)	25,520(2)	D
Common Stock	08/05/2025		S		1,969	D	$30.16(3)	23,551(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.44. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.

2. Includes 4,339 restricted stock units which vest and settle on February 28, 2026 and 19,212 vested restricted stock units which settle within thirty days following the earlier of (i) the termination of the Reporting Person's service for any reason or (ii) a change of control.

3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.69.

	/s/ Ori Lev, attorney-in-fact	08/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the NCSM Form 4 filed on 08/05/2025 disclose?

The Form 4 reports that Director Valerie A. Mitchell sold 2,517 common shares in transactions dated 08/04/2025 and 08/05/2025 and includes RSU details and signature dated 08/05/2025.

How many shares were sold and at what prices?

The filings show 548 shares sold at a weighted-average price of $30.00 and 1,969 shares sold at a weighted-average price of $30.16.

What was the reporting person's beneficial ownership after the transactions?

Beneficial ownership is reported as 25,520 shares after the 08/04 sale and 23,551 shares after the 08/05 sale.

Does the Form 4 disclose restricted stock units (RSUs)?

Yes. The filing includes 4,339 RSUs that vest on 02/28/2026 and 19,212 vested RSUs that settle within 30 days after termination or a change of control.

Who signed the Form 4 and when was it signed?

The Form 4 is signed by attorney-in-fact Ori Lev and dated 08/05/2025.

Are detailed per-transaction price breakdowns provided?

The filing reports weighted-average price ranges and states the reporting person will provide a full breakdown of the number of shares sold at each separate price upon request; reported ranges include $30.00–$30.44 and $30.00–$30.69.